Insufficient scRNA-seq data for expression of TNFSF15 at single-cell level.
Insufficient scRNA-seq data for expression of TNFSF15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 98% | 575.88 | 946 / 966 | 93% | 8.03 | 492 / 527 |
prostate | 99% | 1048.41 | 242 / 245 | 87% | 7.25 | 436 / 502 |
stomach | 89% | 292.15 | 318 / 359 | 93% | 7.81 | 267 / 286 |
thymus | 97% | 181.76 | 632 / 653 | 75% | 5.84 | 455 / 605 |
lung | 98% | 534.46 | 565 / 578 | 74% | 7.29 | 849 / 1155 |
bladder | 76% | 457.43 | 16 / 21 | 72% | 6.45 | 362 / 504 |
kidney | 100% | 907.39 | 89 / 89 | 46% | 2.45 | 415 / 901 |
esophagus | 57% | 158.27 | 823 / 1445 | 73% | 6.14 | 133 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.91 | 1 / 1 |
adrenal gland | 91% | 176.10 | 234 / 258 | 3% | 0.13 | 7 / 230 |
breast | 42% | 53.53 | 193 / 459 | 41% | 2.71 | 456 / 1118 |
pancreas | 17% | 17.16 | 57 / 328 | 61% | 2.93 | 108 / 178 |
uterus | 31% | 35.44 | 52 / 170 | 47% | 2.52 | 215 / 459 |
spleen | 73% | 83.74 | 175 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 4.02 | 29 / 45 |
skin | 42% | 45.18 | 762 / 1809 | 15% | 0.78 | 70 / 472 |
adipose | 47% | 64.45 | 570 / 1204 | 0% | 0 | 0 / 0 |
ovary | 8% | 5.64 | 14 / 180 | 39% | 1.48 | 169 / 430 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.98 | 13 / 29 |
liver | 12% | 8.36 | 26 / 226 | 18% | 1.28 | 75 / 406 |
peripheral blood | 22% | 39.54 | 200 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 18% | 17.80 | 245 / 1335 | 0% | 0 | 0 / 0 |
brain | 3% | 2.84 | 90 / 2642 | 1% | 0.02 | 4 / 705 |
heart | 2% | 1.96 | 20 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.35 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0006955 | Biological process | immune response |
GO_0007250 | Biological process | activation of NF-kappaB-inducing kinase activity |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005164 | Molecular function | tumor necrosis factor receptor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | TNFSF15 |
Protein name | Tumor necrosis factor (Ligand) superfamily, member 15 Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Cleaved into: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form] TNF superfamily member 15 |
Synonyms | TL1 VEGI |
Description | FUNCTION: Receptor for TNFRSF25 and TNFRSF6B. Mediates activation of NF-kappa-B. Inhibits vascular endothelial growth and angiogenesis (in vitro). Promotes activation of caspases and apoptosis. . |
Accessions | D9N2U0 ENST00000374045.5 [O95150-1] X6R8I9 ENST00000374044.1 O95150 |